Technology | ECG Monitoring Services | July 13, 2017

Cardiologs ECG Analysis Platform Receives FDA Clearance

Cloud-based, artificial intelligence-powered ECG analysis solution aids healthcare professionals in screening for arrhythmias using ambulatory ECG monitoring recordings

Cardiologs ECG Analysis Platform Receives FDA Clearance

July 13, 2017 — Cardiologs Technologies SAS announced that it has received U.S. Food and Drug Administration (FDA) clearance of its Cardiologs ECG Analysis Platform, a cloud-based cardiac monitoring-analysis web service powered by artificial intelligence (AI). Cardiologs aids physicians in screening for atrial fibrillation (AFib) and other arrhythmias using long-term ambulatory electrocardiogram (ECG) monitoring recordings. The Cardiologs system is also CE marked in Europe.

Atrial fibrillation (AFib) is the most common human arrhythmia, affecting about 33 million patients worldwide. AFib is a growing problem in cardiovascular disease and is associated with an increased risk of severe stroke, heart failure and death. AFib is often asymptomatic, with stroke as the first manifestation. Indeed, recent stroke registries indicate that AFib is associated with one-third of all ischemic strokes.

“It is intuitive that screening for AFib and subsequent anticoagulant treatment should reduce the stroke burden, which is the basis of guideline recommendations to screen for AFib in persons over the age of 65,” said Arnaud Rosier, M.D., cardiac electrophysiologist at the Hôpital Jacques Cartier, Massy, France. “Unfortunately, current R-R interval based methods to detect AFib are characterized by an inferior positive predictive value (PPV) of under 59 percent, leading to misdiagnoses, mostly false positives, that add significant cost to the healthcare system while burdening healthcare resources and placing unnecessary stress on misdiagnosed patients or putting undiagnosed patients in harm’s way.”

A cardiologist recovers a digital ECG from any compatible cardiac monitoring device — such as a Holter monitor, smartwatch, ECG patch or even a connected t-shirt — then uploads it to the Cardiologs cloud and is able to immediately leverage the technology to identify relevant events. It is especially powerful for long-term recordings that used to require a very laborious manual analysis process, according to Yann Fleureau, co-founder and CEO of Cardiologs Technologies. He said the neural network was developed using more than 500,000 recordings, and the training dataset continues to grow.

When defining the reliability of diagnosing AFib and other arrhythmias, the term positive predictive value (PPV) refers to the percentage of true positive cases among total cases detected. Conventional PPV for detecting AFib is less than 59 percent. The PPV for Cardiologs’ detection of AFib was 91 percent, included in the cleared FDA submission. In addition, also as included in the cleared FDA submission, Cardiologs’ sensitivity for detecting AFib was reported to be 97 percent (the percentage of positive cases truly identified) and was superior to  conventional methods of detecting AFib and other arrhythmias. Cardiologs’ study results have been published in the European Journal of Preventive Cardiology (2016, Vol. 23(2S 41-55). The study’s investigators concluded: “This (Cardiologs) method may be more reliable and accurate than previous methods in the diagnosis of AFib on long-duration ambulatory ECG and other monitoring devices.”

For more information: www.cardiologs.com

Related Content

New Consensus Document Explores Ethical Use of AI in Radiology
News | Artificial Intelligence | March 05, 2019 | Jeff Zagoudis, Associate Editor
The American College of Radiology (ACR) is one of seven professional societies behind a new consensus document on the...
RSNA Offers First U.S. Spotlight Course on Artificial Intelligence
News | Artificial Intelligence | March 05, 2019
The Radiological Society of North America (RSNA) announced an expansion of its artificial intelligence (AI) education...
ACC Future Hub

Presenter delivers pitch at last year’s ACC Future Hub. This year during ACC.19, entrepreneurs will pitch software and hardware specific to cardiology in two categories– artificial intelligence and digitally enabled medical devices. (Image courtesy of ACC)

Feature | Artificial Intelligence | March 01, 2019 | By Greg Freiherr
Entrepreneurs to pitch innovative ideas at ACC
Siemens Healthineers Demonstrates Artificial Intelligence, Healthcare Digitalization at HIMSS19
News | Artificial Intelligence | February 13, 2019
At the 2019 Healthcare Information and Management Systems Society (HIMSS) global conference and exhibition, Feb. 11-15...
Medical Imaging AI Fundings Tops $1.2 Billion Worldwide
News | Artificial Intelligence | February 04, 2019
In 2018, capital investment in companies developing artificial intelligence (AI)-enabled medical image analysis...
Siemens Healthineers Debuts AI-Rad Companion Chest CT
News | Artificial Intelligence | January 25, 2019
January 25, 2019 — Siemens Healthineers presented its first intelligent software assistant for radiology, the AI-Rad
Artificial Intelligence in medical imaging was the top trend and buzz at RSNA 2018.

Artificial intelligence in medical imaging was the major buzz at RSNA 2018. The expo floor had a dedicated area just to highlight artificial intelligence software for medical imaging. More than 150 vendors on the expo floor were showing software using some level of AI or deep learning. 

Feature | Artificial Intelligence | January 17, 2019 | Dave Fornell, Editor
Artificial intelligence (AI) was by far the hottest trend discussed in sessions and across the expo floor at the worl
Artificial Intelligence Advances Threaten Privacy of Health Data
News | Artificial Intelligence | January 04, 2019
Advances in artificial intelligence (AI) have created new threats to the privacy of people's health data, a new...
Videos | Artificial Intelligence | December 12, 2018
This is a quick video tour of the Machine Learning Showcase at the ...
Overlay Init